Danish Biotechnology Genmab (GMAB) In advanced discussions to acquire Miros (Nasdak:MruOn Sunday, Bloomberg News mentioned a Dutch drug developer targeting head and neck cancer. After receiving an interest in seizing many large vital medications https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2223638914/image_2223638914.jpg?io=getty-c-w750 Source link
